Business model

The business model of Respiratorius is focused on value creation in the preclinical phase of candidate drugs for cancer, COPD/asthma, and cardiovascular diseases.

Respiratorius is actively seeking partnership with Big Pharma companies for continued development of the candidate drugs. The ideal partner has the capacity to finance and lead the clinical development and assume responsibility for production, marketing and sales.